
InMode Ltd. – NASDAQ:INMD
InMode Ltd. stock price today
InMode Ltd. stock price monthly change
InMode Ltd. stock price quarterly change
InMode Ltd. stock price yearly change
InMode Ltd. key metrics
Market Cap | 1.44B |
Enterprise value | 2.79B |
P/E | 18.28 |
EV/Sales | 6.15 |
EV/EBITDA | 13.59 |
Price/Sales | 6.35 |
Price/Book | 5.20 |
PEG ratio | -7.92 |
EPS | 2.17 |
Revenue | 466.25M |
EBITDA | 173.35M |
Income | 181.11M |
Revenue Q/Q | -24.31% |
Revenue Y/Y | -1.72% |
Profit margin | 35.56% |
Oper. margin | 43.55% |
Gross margin | 83.82% |
EBIT margin | 43.55% |
EBITDA margin | 37.18% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInMode Ltd. stock price history
InMode Ltd. stock forecast
InMode Ltd. financial statements
$26
Potential upside: 81.81%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 136.08M | 55.72M | 40.95% |
---|---|---|---|
Sep 2023 | 123.11M | 46.52M | 37.79% |
Dec 2023 | 126.78M | 55.16M | 43.51% |
Mar 2024 | 80.28M | 23.69M | 29.52% |
Jun 2023 | 734084000 | 67.92M | 9.25% |
---|---|---|---|
Sep 2023 | 793530000 | 70.03M | 8.83% |
Dec 2023 | 863286000 | 75.91M | 8.79% |
Mar 2024 | 891735000 | 76.3M | 8.56% |
Jun 2023 | 53M | 13.00M | 827K |
---|---|---|---|
Sep 2023 | 41.44M | -69.82M | 2.72M |
Dec 2023 | 61.26M | -51.69M | 275K |
Mar 2024 | 24.11M | -47.39M | 234K |
InMode Ltd. alternative data
InMode Ltd. Social Media Accounts
May 2025 | 104989 |
---|---|
Jul 2025 | 105952 |
Aug 2025 | 106385 |
InMode
21 May 2023 | 39 |
---|---|
28 May 2023 | 39 |
4 Jun 2023 | 33 |
11 Jun 2023 | 29 |
18 Jun 2023 | 47 |
25 Jun 2023 | 28 |
2 Jul 2023 | 41 |
9 Jul 2023 | 42 |
16 Jul 2023 | 38 |
23 Jul 2023 | 36 |
30 Jul 2023 | 47 |
6 Aug 2023 | 31 |
13 Aug 2023 | 29 |
20 Aug 2023 | 32 |
27 Aug 2023 | 37 |
3 Sep 2023 | 35 |
10 Sep 2023 | 27 |
17 Sep 2023 | 29 |
24 Sep 2023 | 29 |
1 Oct 2023 | 25 |
Non invasive Treatment
13 Aug 2023 | 62 |
---|---|
20 Aug 2023 | 53 |
27 Aug 2023 | 51 |
3 Sep 2023 | 60 |
10 Sep 2023 | 55 |
17 Sep 2023 | 44 |
24 Sep 2023 | 45 |
1 Oct 2023 | 57 |
8 Oct 2023 | 37 |
15 Oct 2023 | 40 |
22 Oct 2023 | 34 |
29 Oct 2023 | 45 |
5 Nov 2023 | 44 |
12 Nov 2023 | 36 |
19 Nov 2023 | 49 |
26 Nov 2023 | 60 |
3 Dec 2023 | 52 |
10 Dec 2023 | 49 |
17 Dec 2023 | 56 |
24 Dec 2023 | 49 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
Aug 2023 | 10 |
---|---|
Sep 2023 | 13 |
Oct 2023 | 8 |
Nov 2023 | 2 |
Dec 2023 | 4 |
Jan 2024 | 1 |
Feb 2024 | 0 |
Apr 2024 | 1 |
May 2024 | 2 |
Jun 2024 | 5 |
Jul 2024 | 8 |
Dec 2024 | 13 |
Jan 2025 | 13 |
Feb 2025 | 15 |
May 2025 | 8 |
Jul 2025 | 0 |
Aug 2025 | 0 |
Aug 2023 | 480 |
---|---|
Sep 2023 | 480 |
Oct 2023 | 480 |
Nov 2023 | 480 |
Dec 2023 | 480 |
Jan 2024 | 480 |
Feb 2024 | 480 |
Mar 2024 | 581 |
Apr 2024 | 581 |
May 2024 | 581 |
Jun 2024 | 581 |
Jul 2024 | 581 |
InMode Ltd. other data
Patent |
---|
Application Filling date: 4 Nov 2021 Issue date: 24 Feb 2022 |
Application Filling date: 18 Sep 2020 Issue date: 27 Jan 2022 |
Application Filling date: 15 Mar 2020 Issue date: 16 Sep 2021 |
Application Filling date: 24 May 2021 Issue date: 9 Sep 2021 |
Application Filling date: 3 Dec 2020 Issue date: 10 Jun 2021 |
Application Filling date: 8 Feb 2021 Issue date: 3 Jun 2021 |
Application Filling date: 8 Feb 2021 Issue date: 3 Jun 2021 |
Application Filling date: 27 Aug 2020 Issue date: 17 Dec 2020 |
Application Filling date: 6 Mar 2020 Issue date: 10 Sep 2020 |
Application Filling date: 16 May 2018 Issue date: 21 Nov 2019 |
Quarter | Transcript |
---|---|
Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 13 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Shakil Lakhani (1983) Pres of North America | $2,050,000 |
Dr. Spero Theodorou M.D. (1972) Chief Medical Officer | $1,620,000 |
Mr. Yair Malca (1978) Chief Financial Officer | $429,000 |
Dr. Michael Kreindel (1968) Chief Technology Officer & Director | $217,000 |
Mr. Moshe Mizrahy (1953) Chairman & Chief Executive Officer | $216,000 |
InMode: A Clear Bargain With Unique Risks
InMode: Clearly, I Was Too Optimistic (Rating Downgrade)
InMode: Product Origination And Undervaluation Make The Stock A Buy
InMode: Reversing Previous Shareholder Dilution With Buybacks
InMode: Take The Plunge Before It Goes Into Beast Mode
InMode: Good Margin Of Safety At Current Levels
InMode: Despite Attractive Valuation, I Believe It's Premature To Dive In - Here's Why
InMode Is Inherently Undervalued - Bullish Support Observed
InMode: Buying Opportunity At Oversold Market Levels
-
What's the price of InMode Ltd. stock today?
One share of InMode Ltd. stock can currently be purchased for approximately $14.3.
-
When is InMode Ltd.'s next earnings date?
Unfortunately, InMode Ltd.'s (INMD) next earnings date is currently unknown.
-
Does InMode Ltd. pay dividends?
No, InMode Ltd. does not pay dividends.
-
How much money does InMode Ltd. make?
InMode Ltd. has a market capitalization of 1.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8.32% to 492.05M US dollars.
-
What is InMode Ltd.'s stock symbol?
InMode Ltd. is traded on the NASDAQ under the ticker symbol "INMD".
-
What is InMode Ltd.'s primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of InMode Ltd.?
Shares of InMode Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are InMode Ltd.'s key executives?
InMode Ltd.'s management team includes the following people:
- Mr. Shakil Lakhani Pres of North America(age: 42, pay: $2,050,000)
- Dr. Spero Theodorou M.D. Chief Medical Officer(age: 53, pay: $1,620,000)
- Mr. Yair Malca Chief Financial Officer(age: 47, pay: $429,000)
- Dr. Michael Kreindel Chief Technology Officer & Director(age: 57, pay: $217,000)
- Mr. Moshe Mizrahy Chairman & Chief Executive Officer(age: 72, pay: $216,000)
-
How many employees does InMode Ltd. have?
As Jul 2024, InMode Ltd. employs 581 workers.
-
When InMode Ltd. went public?
InMode Ltd. is publicly traded company for more then 6 years since IPO on 8 Aug 2019.
-
What is InMode Ltd.'s official website?
The official website for InMode Ltd. is inmodemd.com.
-
How can i contact InMode Ltd.?
InMode Ltd. can be reached via phone at +972 4 909 6313.
-
What is InMode Ltd. stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for InMode Ltd. in the last 12 months, the avarage price target is $26. The average price target represents a 81.81% change from the last price of $14.3.
InMode Ltd. company profile:

InMode Ltd.
inmodemd.comNASDAQ
581
Medical - Devices
Healthcare
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Yokne'am, 2069206
CIK: 0001742692
ISIN: IL0011595993
CUSIP: M5425M103